BTSG
BrightSpring Health Services, Inc. Common Stock
BTSG's fundamentals are strong: revenue grew 23% and free cash flow grew 78%. At 39x earnings, it's trading below its usual 54x. Analysts expect that strong growth to continue, though they disagree widely on how much.
BTSG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Stable |
BTSG's revenue, profitability and cash flow are currently healthy, and its balance sheet is stable.
BTSG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 30x | $71.45 | — |
| Cheap | 38x | $69.24 | -3.1% |
| Current | 39x | $71.45 | — |
| Fair | 53x | $98.23 | +37% |
| Expensive | 72x | $132 | +84% |
Historical ranges are pointers, not guarantees.
BTSG's PE is in its cheap range at 39x. If earnings grow as analysts expect, today's price would be 30x next year's earnings.
BTSG Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for BTSG, with profitability improving. However, they disagree widely on these estimates.
BTSG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.37 | +29% |
| Q3 2026 | $1.84 | +188% |
| Q2 2026 | $1.65 | +385% |
| Q1 2026 | $1.40 | +352% |
| Q4 2025 | $0.87 | +$0.96 |
| Q3 2025 | $0.64 | +$0.88 |
| Q2 2025 | $0.34 | +$1.30 |
| Q1 2025 | $0.31 | +$1.34 |
| Q4 2024 | -$0.09 | +$0.80 |
BTSG's earnings per share have climbed steadily: $1.84 over the past year, up 188% from the year before, and higher year over year for nine quarters in a row.
BTSG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.2B | +26% |
| Q2 2026 | $3.9B | +23% |
| Q1 2026 | $3.6B | +26% |
| Q4 2025 | $3.6B | +16% |
| Q3 2025 | $3.3B | +15% |
| Q2 2025 | $3.1B | +15% |
| Q1 2025 | $2.9B | +12% |
| Q4 2024 | $3.1B | +29% |
BTSG's revenue has grown year over year every quarter since late 2020: $4.2B last quarter, up 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.8% | +1.2 points |
| Q2 2026 | 3.4% | +1.8 points |
| Q1 2026 | 3.4% | +1.6 points |
| Q4 2025 | 3% | +0.5 points |
| Q3 2025 | 2.6% | +0.7 points |
| Q2 2025 | 1.5% | -0.8 points |
| Q1 2025 | 1.8% | +1.4 points |
| Q4 2024 | 2.6% | -0.3 points |
BTSG's operating margin was 3.8% last quarter, up 1.2 points from the same quarter a year ago.
BTSG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $182.2M | +98% |
| Q2 2026 | $14.9M | -40% |
| Q1 2026 | $101.4M | +21% |
| Q4 2025 | $193.9M | +157% |
| Q3 2025 | $92.2M | +1180% |
| Q2 2025 | $24.7M | +$63.6M |
| Q1 2025 | $84M | +$184.6M |
| Q4 2024 | $75.3M | -48% |
BTSG generated $492M in free cash flow over the past year, up 78% from the year before.
BTSG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -50K shares |
| 1 year | +1% | +2.2M shares |
| 3 years | +29% | +49M shares |
| 5 years | +29% | +49M shares |
| Available history | +53% | +76.1M shares |
BTSG has 220M diluted shares, up 1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $60M |
| Q1 2026 | $60M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $325,000 |
| Q1 2024 | $325,000 |
| Q4 2023 | $325,000 |
BTSG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.2x | Moderate |
| Q2 2026 | 2.7x | Moderate |
| Q1 2026 | 3.1x | Elevated |
| Q4 2025 | 5.3x | High |
| Q3 2025 | 5.3x | High |
| Q2 2025 | 5.8x | High |
| Q1 2025 | 5.6x | High |
| Q4 2024 | 6.2x | High |
BTSG's net debt is about 2.2 years of its operating earnings (EBITDA), down from 5.3 years a year ago.
BTSG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.6 | Neutral |
| Stochastic | 76.0 | Neutral |
BTSG's weekly RSI is 67 (neutral) and its Stochastic is 76 (neutral).
BTSG PE vs Healthcare Sector
| Metric | BTSG | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 26x | 50% above |
| PE % | 20 | 45 | 25 pts below |
BTSG is trading at 39x earnings, a 50% premium to the Healthcare sector's median of 26x.
BTSG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $63.4 | 13% above |
| 20 week MA | $63.5 | 13% above |
| 50 week MA | $53.2 | 34% above |
| 100 week MA | $38.1 | 87% above |
BTSG is in an uptrend: it's above all four of its weekly moving averages, and 87% above its 100-week average.
BTSG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $11.0 | $17.0 | +55% |
| 2025 | $17.0 | $37.8 | +122% |
| 2026 YTD | $37.8 | $71.5 | +89% |
BTSG has finished every year since 2024 higher, and it's up 89% so far in 2026.